A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2006
11/08/2006	CN1283267C Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method
11/08/2006	CN1283261C Water-soluble propolis liquor and its preparation method
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/08/2006	CN1283237C Curcumin and phosphatide composite and its preparation method
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132537 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132456 MCH receptor antagonists
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2248032C Serum cholesterol lowering agent
11/07/2006	CA2158268C N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
11/02/2006	WO2006116470A1 Use of metformin to counteract weight gain associated with aripiprazole or ziprasidone treatment
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006115297A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115154A1 Crystal polymorphism of 4’-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3’,5’-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	WO2006115130A1 Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
11/02/2006	WO2006115115A1 Combined pharmaceutical preparation for treatment of type 2 diabetes
11/02/2006	WO2006114439A2 Novel nutraceutical compositions
11/02/2006	WO2006114402A1 Substituted octahydroisoindoles as antagonists of melanin concentrating hormone receptor 1 (mch1r)
11/02/2006	WO2006114284A2 AGONISTIC ANTIBODIES THAT BIND TO THE LT-β-RECEPTOR AND THEREBY MODULATE ADIPOSITY-ASSOCIATED PHENOTYPES AS WELL AS THEIR USE IN THERAPY
11/02/2006	WO2006114195A1 Compositions comprising tripeptides inhibiting ace
11/02/2006	WO2006114194A1 Peptides having a health benefit and compositions comprising them
11/02/2006	WO2006114190A1 Novel specific caspase-10 inhibitors
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2006086727A3 Treating diabetes with glucagon-like peptide-1 secretagogues
11/02/2006	WO2006067224A3 Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
11/02/2006	WO2006051110A3 Stable formulations of insulinoptropic peptides
11/02/2006	WO2006034373A3 Variants and chemically-modified variants of phenylalanine ammonia-lyase
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247439 Mchir antagonists
11/02/2006	US20060247312 Composition comprising free amino acids
11/02/2006	US20060247310 Body temperature elevating agents
11/02/2006	US20060247309 Compounds for the treatment of metabolic disorders
11/02/2006	US20060247307 imino compound as antiinflammatory agent, anticarcinogenic agent for treating chronic inflammation and cancers; activating peroxisome proliferator-activated receptor
11/02/2006	US20060247302 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/02/2006	US20060247299 administering HMG-CoA reductase inhibitor; for treatment of diabetes and complications caused by insulin resistance syndrome
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247268 N-sulfonylaminothiazole
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060247174 Use of a peptide
11/02/2006	US20060247171 Use of a peptide
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246538 Capable of sodium-independently transporting branched amino acids
11/02/2006	US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246047 Peptide wirh apoptosis-inhibiting activity
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716137A1 Substituted quinoline compounds
11/02/2006	EP1716132A2 Spiro-benzodioxoles and their use as cb1 antagonists
11/02/2006	EP1715881A1 Cysteine rich peptides for improving thiol homeostasis
11/02/2006	EP1715878A2 Use of an extract of pueraria tuberosa for the treatment of diabetes type 2
11/02/2006	EP1715877A1 Compositions and methods for reducing cholesterol comprising guggul and beta-glucan and/or plant sterols
11/02/2006	EP1715865A2 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1715857A1 Amidine derivatives for treating amyloidosis
11/02/2006	EP1501565B1 Compounds and method for coating surfaces in a haemocompatible manner
11/02/2006	EP1480663B1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1400246B1 Oral compositions for the treatment of obese, non-diabetic mammals, including humans
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1377278B1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
11/02/2006	EP1359926B1 An anti-diabetic agent obtained from the plant humboldtia decurrens and a process for preparing the same
11/02/2006	EP1343773B1 Thiazole derivatives for traeing ppar related disorders
11/02/2006	EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases

1 ... 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 ... 1298